It was reported that the patient with this cardiac resynchronization therapy defibrillator (crt-d) entered in an intrinsic ventricular arrythmia episode.The device appropriately detected the ventricular arrhythmia and the patient returned to normal sinus rhythm on their own, therefore, shock therapy was successfully diverted.Subsequently the patient continued to have short episodes of ventricular arrhythmia where they converted on their own, but the device therapy was already committed to be delivered, thus inappropriately delivered shock therapy for normal sinus rhythm.Eventually the therapy was exhausted.The patient stabilized in part due to medication being given.Technical services discussed further device programing and optimization.This device remains in service.No further adverse patient effects were reported.
|